Cure My Disease

Don't miss your cure!

 Log in / Sign up

Your personality could be key to sticking with CML treatment

NCT ID NCT06229860

Recruiting now Knowledge-focused Sponsor: University of California, Irvine Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study explores whether a person's personality traits influence how well they take their daily leukemia pills. Researchers will interview 75 adults with chronic myeloid leukemia and use questionnaires to measure medication adherence, personality, and quality of life. The goal is to find patterns that could help tailor support for patients.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If successful, this study could help doctors identify patients who may need extra support to take their leukemia medication consistently.
What could go wrong
This is a small, observational pilot study—it does not test a new treatment. Results may not apply to all CML patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC MYELOID LEUKEMIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

chronic myelogenous leukemia, BCR-ABL1 positive Leukemia, Myelogenous, Chronic, BCR-ABL Positive Leukemia, Myeloid, Chronic-Phase

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CHRONIC MYELOID LEUKEMIA CHRONIC PHASE CHRONIC MYELOGENOUS LEUKEMIA

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

Locations

  • Chao Family Comprehensive Cancer Center University of California, Irvine

    RECRUITING

    Orange, California, 92868, United States

    Contact Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.